-
Product Insights
Likelihood of Approval Analysis for Actinic (Solar) Keratosis
Overview How likely is it that the drugs in Actinic (Solar) Keratosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Actinic (Solar) Keratosis Overview An actinic keratosis, also known as a...
-
Product Insights
Likelihood of Approval Analysis for Allergic Rhino-Conjunctivitis
Overview How likely is it that the drugs in Allergic Rhino-Conjunctivitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergic Rhino-Conjunctivitis Overview Allergic Rhino-Conjunctivitis is an allergen-induced inflammatory response mediated by...
-
Thematic Analysis
NewFoodservices M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Foodservice Sector
-
Thematic Analysis
NewAerospace, Defense and Security M&A Deals Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Aerospace, Defense and Security Sector
-
Product Insights
JRCS – Kuriyama Red Cross Hospital facility development – Hokkaido
The JRCS – Kuriyama Red Cross Hospital facility development – Hokkaido project involves the construction of an 8765m2, five-story hospital with 103 beds on 1.58ha of land in Hokkaido, Japan. Equip yourself with the essential tools needed to make informed and profitable decisions with our JRCS – Kuriyama Red Cross Hospital facility development – Hokkaido report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of...
-
Product Insights
Likelihood of Approval Analysis for Thalassemia
Overview How likely is it that the drugs in Thalassemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thalassemia Overview Thalassemia is a group of inherited blood disorders that affect the...
-
Product Insights
Likelihood of Approval Analysis for Rhino-Conjunctivitis
Overview How likely is it that the drugs in Rhino-Conjunctivitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rhino-Conjunctivitis Overview Rhinitis is characterized by one or several of the following symptoms:...
-
Product Insights
Likelihood of Approval Analysis for Pertussis (Whooping Cough)
Overview How likely is it that the drugs in Pertussis (Whooping Cough) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pertussis (Whooping Cough) Overview Pertussis, also known as whooping cough, is...
-
Product Insights
Likelihood of Approval Analysis for Kaposi Sarcoma
Overview How likely is it that the drugs in Kaposi Sarcoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Kaposi Sarcoma Overview Kaposi's sarcoma is a cancer that causes patches of...
-
Product Insights
Likelihood of Approval Analysis for Grass Pollen Allergy
Overview How likely is it that the drugs in Grass Pollen Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Grass Pollen Allergy Overview Grass pollen allergy is a reaction which...